Thursday, February 28, 2019 9:03:58 AM
After patiently waiting for quite a while I decided now is the time.
Here are the reasons why.
Reason #1: CELZ has found a steady price around a penny for some time now. It's stabilized here and has churned around indicating that this is in all likelihood it's turning point.
Reason #2: CELZ is a legitimate startup company with treatment centers and doctors coming on board constantly. They announced their over all marketing strategies last year and have delivered way more than the average observer knows. I'll get to that here in a minute.
Reason #3: Management does not pump this stock. They're building a company, not a share selling scheme. They never publish fluff like 99% of the garbage stocks do. They're to busy building their base for future growth.
Reason #4: This is what the average investor doesn't know about CELZ. As a Internet Marketing specialist, I've looked at their website and it's code. It utilizes the WordPress platform which is the most successful CONTENT MANAGED SYSTEM on the www.
In addition they're using the DIVI THEME. This is one of the most successful themes out of the thousands available. If you google "most used WordPress themes" you will see it come up #1.
Beyond that they have correctly deployed YOAST SEO on their site. That it's correctly configured is huge. I am a specialist with YOAST and most new clients I take on it's a wreck and needs fixing.
I see in their code where they have installed GOOGLE TAG MANAGER for their paid marketing campaigns.
I see in their codes META SECTION where they have a GOOGLE SITE VERIFICATION TAG installed so that their GOOGLE SEARCH CONSOLE is functional and their site is claimed.
I see where their GLOBAL SITE TAG is properly installed for their ADWORDS CAMPAIGNS.
I see 6 GOOGLE TRACKING TAGS. 1 for their text ads. And 5 for the 5 cities they're doing paid ads in, along with the phone numbers being tracked.
And I see a GOOGLE ANALYTICS TAG so that all of this different data, and the sources of website tracking can be monitored on a granular level.
In addition I tested their code with googles structured data testing tool. Unlike 95% if sites I test https://www.caverstem.com comes up with no errors and no warnings. This is very rare. Very, very rare and indicates to me that this marketing campaign is being managed by a very high end professional like myself. And we do not come cheap.
Beyond all of this I used SEO SPYGLASS from LINK ASSISTANT to test the backlinks that point at CELZ and find over 500 which is very good. Backlinks are one of the primary factors a site needs to acheive rankings in the search engines.
I've watched this site and CELZ's overall internet marketing strategy evolve for just about one year now. Everything I see tells me that this start up company has big plans, and they're building this system so that it's scale-able. The short of it is they intend to take over the world of erectile dysfunction with a cure, not a treatment. And they're taking it over via online marketing.
Reason #5: SeatonBM is back and says it's a go! He's an excellent chartist and brings a history of having called almost every move on CELZ in the past perfectly. That I was watching it and thinking about getting back in at the same time as him caused me to pull the trigger.
Very soon CELZ will publish their test results and I expect them to be very good. At that time we will head north and it could be any day now.
Good luck to all of you investors! And I hope you make lots of money!
Recent CELZ News
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/03/2023 08:05:12 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 09:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 01:00:18 PM
- Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements • PR Newswire (US) • 06/28/2023 12:00:00 PM
- Creative Medical Technology Announces $2 Million Share Repurchase Program • PR Newswire (US) • 06/12/2023 12:01:00 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 06/12/2023 12:00:00 PM
- Creative Medical Technology Holdings Announces Reverse Stock Split • PR Newswire (US) • 06/09/2023 04:30:00 PM
- Creative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immunotherapy Platform • PR Newswire (US) • 05/31/2023 12:00:00 PM
- Creative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz® Platform Development • PR Newswire (US) • 05/22/2023 12:30:00 PM
- Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell Line • PR Newswire (US) • 05/18/2023 12:00:00 PM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM